Neratinib after trastuzumab in patients with HER2-positive breast cancer – Author's reply. Issue 5 (May 2016)

Record Type:: Journal Article
Title:: Neratinib after trastuzumab in patients with HER2-positive breast cancer – Author's reply. Issue 5 (May 2016)
Main Title:: Neratinib after trastuzumab in patients with HER2-positive breast cancer – Author's reply
Authors:: Chan, Arlene
Buyse, Marc
Yao, Bin
Abstract:
Is Part Of:: Lancet oncology. Volume 17:Issue 5(2016:May)
Journal:: Lancet oncology
Issue:: Volume 17:Issue 5(2016:May)
Issue Display:: Volume 17, Issue 5 (2016)
Year:: 2016
Volume:: 17
Issue:: 5
Issue Sort Value:: 2016-0017-0005-0000
Page Start:: e176
Page End:: e177
Publication Date:: 2016-05
Subjects:: Oncology -- Periodicals
Neoplasms -- Periodicals
Cancérologie -- Périodiques
Oncologie
Oncology
Periodicals
Electronic journals
616.994005
Journal URLs:: http://www.sciencedirect.com/science/journal/14702045 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S1470-2045(16)30018-3 ↗
Languages:: English
ISSNs:: 1470-2045
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5146.090000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 1915.xml